EP
ABMD

Edgestream Partners’s Abiomed Inc ABMD Stock Holding History

Edgestream Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,059
Closed -$3.6M – 607
2021
Q3 		$3.6M Buy
11,059
+725
+7% +$246K 0.22% 159
2021
Q2 		$3.23M Buy
+10,334
New +$3.17M 0.19% 177

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Edgestream Partners's ABMD Position: Q4 2021 in Review

Edgestream Partners sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 11,059 shares — an estimated $3.6M sold.

Edgestream Partners first reported a position in ABMD in Q2 2021 and held it in 2 quarters. The position peaked at $3.6M in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Edgestream Partners reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Edgestream Partners sold 11,059 Abiomed Inc shares in Q4 2021, an estimated $3.6M.
  • Edgestream Partners first reported a position in Abiomed Inc in Q2 2021 and held it in 2 quarters.
  • Edgestream Partners's Abiomed Inc position peaked at $3.6M in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Edgestream Partners's 13F filing for Q4 2021, filed 15 Feb 2022.